Should I accept this kidney?
- 1 February 2000
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 14 (1) , 90-95
- https://doi.org/10.1034/j.1399-0012.2000.140117.x
Abstract
Background. Transplant candidates frequently ask whether they should, based on information available at the time, accept a cadaver kidney or wait for a potentially better one.Methods. We analyzed 937 first and second cadaver transplants done between January 1, 1984 and December 31, 1997 to determine if information available at the time an offer is made could be used to predict long‐term graft survival.Results. By Cox regression, risk factors for worse long‐term graft survival were older donor age, cardiovascular or cerebrovascular cause of donor death, and delayed graft function (DGF). HLA‐ABDR mismatch was marginally significant. Whether DGF will occur is not known at the time of an offer, but risk factors can be determined; we found these to be older donor age and> 10% panel‐reactive antibodies (PRA) at transplantation (by Cox regression). Using these variables (PRA, ABDR mismatch, donor age, and donor cause of death) known at the time of an offer, we calculated the relative risk of worse long‐term graft survival for each subgroup (Table 3in manuscript). In general, older age and donor death from cardiovascular or cerebrovascular disease were associated with worse outcome. Kidneys from donors of <50 yr had the best outcome, irrespective of match.Conclusion. The data provided can be used to help guide patients as to whether they are better off accepting an offered kidney or waiting for a potentially better one. If an offer is declined, the next kidney may have a potentially worse outcome. Relative risk for worse or poor long‐term graft survival, based on information known at the time of a kidney offer: Donor 18–50 yr, other cause of death Donor 18–50 yr, CVD cause of death Donor ≥50 yr, other cause of death Donor ≥50 yr, CVD cause of death Tx PRA (%) ABDR mm (n) RR Rank RR Rank RR Rank RR Rank 0 0 1 1 1.16 3 1.28 6 2.26 25 0 1–6 1.19 4 1.38 10 1.52 14 2.69 27 1–10 0 1.21 5 1.41 11 1.55 17 2.74 28 1–10 1–6 1.44 13 1.67 19 1.84 23 3.25 31 11–75 0 1.12 2 1.30 7 1.43 12 2.53 26 11–75 1–6 1.33 9 1.54 16 1.70 21 3.01 30 76–100 0 1.32 8 1.54 15 1.69 20 3.00 29 76–100 1–6 1.57 18 1.82 22 2.01 24 3.55 32 CVD, cerebrovascular or cardiovascular disease; Tx, transplant; PRA, panel‐reactive antibody; mm, mismatch; RR, relative risk.Keywords
This publication has 12 references indexed in Scilit:
- Decreased Acute Rejection in Kidney Transplant Recipients Is Associated with Decreased Chronic RejectionAnnals of Surgery, 1999
- Risk factors for chronic rejection - a clinical perspectiveTransplant Immunology, 1998
- DELAYED GRAFT FUNCTION, ACUTE REJECTION, AND OUTCOME AFTER CADAVER RENAL TRANSPLANTATIONTransplantation, 1995
- A multicenter experience with sequential ALG/cyclosporine therapy in renal transplantationClinical Transplantation, 1988
- The Benefit of Exchanging Donor Kidneys among Transplant CentersNew England Journal of Medicine, 1988
- DOMINANT EFFECT OF HISTOCOMPATIBILITY ON TEN-YEAR KIDNEY TRANSPLANT SURVIVALTransplantation, 1988
- Long-Term Follow-up in London Transplant Group Recipients of Cadaver Renal AllograftsNew England Journal of Medicine, 1986
- Benefits of HLA-A and HLA-B Matching on Graft and Patient Outcome after Cadaveric-Donor Renal TransplantationNew England Journal of Medicine, 1984
- Effect of HLA-A and HLA-B Matching on Survival of Grafts and Recipients after Renal TransplantationNew England Journal of Medicine, 1982
- CADAVER RENAL TRANSPLANTATION AND HLA MATCHING IN AUSTRALIA FROM 1971 TO 1980Transplantation, 1982